INTRODUCTION
The liver plays a vital role in the coagulation process as it synthesizes and metabolizes the majority of fibrinolytic factors, as well as most proteins which favour and inhibit the process of coagulation and fibrinolysis [1] . Liver failure may disrupt the haemostatic system and decreased levels of most procoagulant factors, leading to severe bleeding or thrombotic complications [2]. However, decreased levels of the procoagulants are accompanied by decreases in levels of such naturally occurring anticoagulants as antithrombin III and protein C [3,4].
Protein C (PC) is a major physiological anticoagulant that is synthesized in the liver, circulates in plasma and is considered a key component of an important natural anticoagulant pathway [5, 6] . It is vitamin K-dependent serine protease enzyme that is activated by thrombin into activated protein C (APC), and the treatment with vitamin K antagonists might further reduce the level of this naturally occurring anticoagulant in patients with liver cirrhosis, increasing the risk of thrombosis [5] .
D-dimer is a Fibrin degradation product (FDP) that represents an accurate marker of fibrinolytic activity [7] . D-dimer The present study aimed to estimate the value of plasma levels of protein C and D-dimer as predictors for diagnosis of PVT in patients with liver cirrhosis.
PATIENTS AND METHODS
This study was conducted in the Tropical Medicine, Internal Medicine and Clinical Pathology Departments, Faculty of Medicine, Zagazig University Hospitals in the period from tune 2014 to July 2015. It included 100 cirrhotic patients. They underwent abdominal ultrasound and dynamic contrast enhanced computed tomography (CT) scans. Therefore, they were classified into two groups as following:
Group 1 (PVT group): It included twenty six cirrhotic patients (22 males and 4 females, mean age 53.60±7.8 years) were diagnosed with PVT.
Group 2 (control group): it included seventy four cirrhotic patients (65 males and 9 females, mean age 54.96 ± 6.5 years) without PVT. -Severity of the liver disease was scored according to Child-Pugh classification.
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Statistical analysis
Continuous variables were expressed as the mean ± SD and the categorical variables were expressed as a number (percentage). Continuous variables were checked for normality by using ShapiroWilk test. Independent Student t-test was used to compare two groups of normally distributed data. Percent of categorical variables were compared using Pearson's Chi-square test. Receiver operating characteristic (ROC) curve analysis was used to identify optimal cut-off values of D-dimer and protein C with maximum sensitivity and specificity for prediction of portal vein thrombosis. Area Under Curve (AUROC) was also calculated, criteria to qualify for AUC were as follows: 0.90 -1 = excellent, 0.80-0.90 = good, 0.70-0.80 = fair; 0.60-0.70= poor; and 0.50-0.6 = fail. The optimal cut-off point was established at point of maximum accuracy. All tests were two sided. P<0.05 was considered statistically significant. All data were analyzed using Statistical Package for Social Science for windows version 18.0 (SPSS Inc., Chicago, IL, USA) & MedCalc for windows version 13 (MedCalc Software bvba, Ostend, Belgium).
RESULTS
Results are shown in the following tables : The liver plays an important role in the coagulation process as it synthesizes and metabolizes the majority of fibrinolytic factors, as well as proteins which favour and inhibit the process of coagulation and fibrinolysis. Liver failure may disrupt the haemostatic system, leading to severe bleeding or thrombotic complications [1,2].
This study found that PT and aPTT were significantly prolonged with the deterioration of liver function from Child-Pugh class A to C, but did not correlate with the formation of PVT. The coagulation function of cirrhotic patients was generally suppressed due to their hepatic failure, which is usually reflected as decreased coagulants. So, they considered as important parameters in indicating liver dysfunction [10,15].
The results showed significantly progressive decreasing of PLT that correlated with the stages of liver dysfunction. These results can be explained as PLT counts were decreased possibly from hypersplenism, decreased production of thrombopoietin synthesis in the liver In the current study plasma protein C concentrations were found to be decreased significantly with deteriorating liver function, such that both ChildPugh class B and class C patients had significantly lower protein C concentrations than class A. So that protein C activity may be used as a sensitive marker of hepatocellular damage [2].
Moreover, plasma PC levels in the PVT group were significantly lower than those in the control group. One of the underlying mechanisms may be due to the fact that hepatocytes fail to synthesize adequate amounts of PC under ischemic and hypoxic conditions. Also, the decrease in PC may be attributed to the endothelial cells damage caused by portal hypertension, which leads to the activation and subsequent consumption of PC in fibrolytic processes [10] .
D-dimer is a fibrin degradation product, a small protein fragment present in the blood after a blood clot is degraded by fibrinolysis [7] . It is a sensitive marker of coagulation and fibrinolysis. Hyperfibrinolysis in cirrhotic patients might represent a state of low grade disseminated intravascular coagulation [24, 25] .
In this study, D-dimer levels were significantly increased from Child-Pugh class A to C so, it was found to have significant correlations with liver dysfunction. Also, D-dimer in the PVT group was significantly higher than this in the control group 
CONCLUSION
The previous data concluded that disturbed coagulation in patients with liver cirrhosis is directly related to the severity of cirrhosis and more importantly, it showed that decreased PC and increased D-dimer values were the risk factors in PVT formation. Therefore, they can suspect the presence of PVT and then specific imaging techniques should be done to confirm the diagnosis and initiate early treatment before the occurrence of serious complications.
RECOMMENDATIONS
Although both coagulation and anticoagulation systems in cirrhotic patients are suppressed as a result of the functional failure of the liver, the two systems may still be maintained. Therefore, there is no tendency for hemorrhage or thrombosis under stable conditions. When cirrhotic patients present under stress, such as sepsis, trauma or scheduled for operative interference, the balance between the two systems is disturbed and those patients should be screened for both coagulation and anticoagulation systems to be managed accurately.
Plasma transfusion (with its contents of coagulant and antithrombotic factors) might be used in particular postoperative decompensation in chronic liver disease patients.
Antithrombotic therapy can be used for recanalization of the portal vein in PVT patients, but evidence for the safety and efficiency of anticoagulants in PVT patients is still lacking and need proper study.
